Zymeworks' Series A - IV Round

Zymeworks raised a round of funding on January 08, 2016.

Zymeworks (NYSE: ZYME) (TSX: ZYME) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of multifunctional biotherapeutics.…

Articles about Zymeworks' Series A - IV Round: